Ledger.Open graph →
SEC Form D · Amendment · filed December 10, 2020

Elucida Oncology, Inc

Offering
$35.0M
Sold
$27.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Monmouth Junction, NJ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Kai Ma · Monmouth Junction, NJExecGeno Germano · Monmouth Junction, NJExec · DirectorTim Boris · Monmouth Junction, NJDirectorMichael Smith · Monmouth Junction, NJDirectorEliel Bayever · Monmouth Junction, NJExecTeresa Ressel · Monmouth Junction, NJDirectorRobert Ruffolo · Monmouth Junction, NJDirectorUlrich Wiesner · Monmouth Junction, NJDirectorRobert Essner · Monmouth Junction, NJExec · DirectorGregory Adams · Monmouth Junction, NJExecAyman M. Shahin · Dubai, C0DirectorJosh Froelich · Houston, TXExecJonathan R. Simon · New York, NYDirectorSpencer Patterson · Orem, UTExec · DirectorJan F. Van Eck · New York, NYDirectorJohn M. Courtright · Elmhurst, ILDirectorMichael Wolfgramm · Orem, UTExec · DirectorJakub Rehor · Reno, NVExecKasper Bihlet · Houston, TXExecRalph Yarro · Orem, UTDirectorDavid Anthony · Broomfield, CODirectorJanice Craig · Vancouver, British Columbia, CanadaDirectorDion F. Chu · New York, NYExec · DirectorMichael F. Peng · New York, NYDirectorHelene Servillon · Dover, DEExec · DirectorKara Forney · Albuquerque, NMDirectorDane F. Lund · New York, NYDirectorVictor D. Woolridge · New York, NYExecJonathan Lamm · New York, NYExecMelissa Weiler · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗